Drugs / PF-06260414
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02393807 | Jun → Jul 2015 | — | Pfizer | Withdrawn | No outcome recorded |
| Phase 1 | NCT02070939 | Feb 2014 → Mar 2015 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-06260414 | “Single dose of 30 mg PF-06260414 given under fasted conditions” NCT02393807 ↗ |
| Modality | Small molecule | — CHEMBL4297476 ↗ |
| Route | Oral | “after oral administration” PMID 27085586 ↗ Apr 2016 |